New Tooth-Saving materials put to the test against standard treatment
NCT ID NCT07660549
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested three different materials used to treat severe, irreversible tooth inflammation. 72 adults with painful molars received a procedure where the damaged pulp was removed and covered with one of the materials. The goal was to see if newer materials (TheraCal LC and TheraCal PT) work as well as the standard material (MTA) for controlling pain and saving the tooth over 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Mineral trioxide aggregate, TheraCal LC, and TheraCal PT (dental pulp capping materials)
What this could lead to
If successful, this could show that newer, easier-to-use materials work as well as the standard material for saving teeth with severe pulp inflammation.
What could go wrong
This is a small, completed trial with only 72 participants, so results may not apply to all patients. The materials are already in use, so no major new breakthrough is expected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULPITIS - IRREVERSIBLE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cukurova University
Adana, Sarıçam, 01250, Turkey (Türkiye)